Effectiveness of the booster dose of COVID-19 vaccine in the Basque Country during the sixth wave: A nationwide cohort study

被引:0
|
作者
Arrospide, A. [1 ,2 ]
Sagardui, M. G. [1 ]
Larizgoitia, I. [1 ]
Iturralde, A. [1 ,3 ]
Moreda, A. [1 ]
Mar, J. [2 ,4 ,5 ]
机构
[1] Minist Hlth Basque Govt, Donostia San Sebastian Kalea 1, Vitoria 01010, Spain
[2] Biodonostia Hlth Res Inst, Econ Evaluat Chron Dis Res Grp, San Sebastian, Spain
[3] Osakidetza Basque Hlth Serv, Directorate Gen, Vitoria, Spain
[4] Debagoiena Integrated Hlth Org, Osakidetza Basque Hlth Serv, Arrasate Mondragon, Spain
[5] Kronikgune Inst Hlth Serv Res, Baracaldo, Spain
关键词
COVID-19; Vaccine; Vaccine booster; Effectiveness; Hospital admissions; Omicron; IMPACT;
D O I
10.1016/j.vaccine.2023.05.061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of the study was to assess the effect of a booster dose of COVID-19 vaccine on the rates of hospital ward and intensive care unit (ICU) admissions around the time of emergence of the Omicron variant in the Basque Country. A retrospective cohort population-based study was conducted. The population with any records related to COVID-19 vaccination up to 28 February 2022 was classified into four cohorts by vaccination status. For every cohort, the hospital ward and ICU admission rates were calculated for each day between November 2021 and February 2022. Generalized linear models with a negative binomial distribution were used to estimate the age-adjusted hospitalization rate ratio of the cohort of individuals who had received a booster compared to the other cohorts. The age-adjusted rates of hospital ward and ICU admissions were 70.4 % and 72.0 % lower, respectively, in the fully vaccinated plus booster group compared to the fully vaccinated but no booster group. Analysing changes in the 14-day admission incidence rates showed that as the prevalence of the Omicron variant increased, the corresponding rate ratios decreased. The immunity acquired with the booster dose allowed the hospital network to meet all the demand for hospitalization during a period of high incidence of COVID-19, despite the fact that vaccine protection decreased as the prevalence of the Omicron variant increased. (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4274 / 4279
页数:6
相关论文
共 50 条
  • [31] New Wave of COVID-19 Vaccine Opinions in the Month the 3rd Booster Dose Arrived
    Delcea, Camelia
    Cotfas, Liviu-Adrian
    Craciun, Liliana
    Molanescu, Anca Gabriela
    VACCINES, 2022, 10 (06)
  • [32] Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia
    Harapan, Harapan
    Fathima, Raisha
    Kusuma, Hendrix Indra
    Anwar, Samsul
    Nalapraya, Widhy Yudistira
    Wibowo, Adityo
    Wati, Ketut Dewi Kumara
    Medina, Ayunda
    Defrita, Anna Hanifa
    Astri, Yesi
    Prasetyowati, Arie
    Nurfarahin, Nurfarahin
    Khusna, Afriyani
    Oktariana, Setya
    Anwar, Sarifuddin
    Yussar, Milza Oka
    Khotimah, Siti
    Nainggolan, Bahagia Willibrordus Maria
    Badri, Putri Rizki Amalia
    Argarini, Raden
    Winardi, Wira
    Indah, Rosaria
    Sallam, Malik
    Rajamoorthy, Yogambigai
    Wagner, Abram L.
    Mudatsir, Mudatsir
    VACCINES, 2022, 10 (12)
  • [33] Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru
    Bendezu-Quispe, Guido
    Caira-Chuquineyra, Brenda
    Fernandez-Guzman, Daniel
    Urrunaga-Pastor, Diego
    Herrera-Anazco, Percy
    Benites-Zapata, Vicente A.
    VACCINES, 2022, 10 (08)
  • [34] Biases in COVID-19 vaccine effectiveness studies using cohort design
    Agampodi, Suneth
    Tadesse, Birkneh Tilahun
    Sahastrabuddhe, Sushant
    Excler, Jean-Louis
    Kim, Jerome Han
    FRONTIERS IN MEDICINE, 2024, 11
  • [35] The attitude of fully vaccinated individuals towards COVID-19 vaccine booster dose: a transverse study from Jordan
    Abuhammad, Sawsan
    Alzoubi, Karem H.
    Khabour, Omar F.
    Hamaideh, Shaher
    El-zubi, Maryam K.
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2022, 13 (04) : 308 - 314
  • [36] Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021
    Marra, Alexandre R.
    Miraglia, Joao Luiz
    Malheiros, Daniel Tavares
    Yang Guozhang
    Teich, Vanessa Damazio
    Victor, Elivane da Silva
    Rebello Pinho, Joao Renato
    Cypriano, Adriana
    Vieira, Laura Wanderly
    Polonio, Miria
    Ornelas, Rafael Herrera
    de Oliveira, Solange Miranda
    Borges Junior, Flavio Araujo
    Cassiano Oler, Silvia Cristina
    Pinto Schettino, Guilherme de Paula
    de Oliveira, Ketti Gleyzer
    Ferraz Santana, Rubia Anita
    Malta, Fernanda de Mello
    Amgarten, Deyvid
    Boechat, Ana Laura
    Zimpel Trecenti, Noelly Maria
    Kobayashi, Takaaki
    Salinas, Jorge L.
    Edmond, Michael B.
    Rizzo, Luiz Vicente
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E360 - E366
  • [37] The Effectiveness of the Third Dose of COVID-19 Vaccine: When Should It Be Performed?
    Biganzoli, Giacomo
    Mendola, Marco
    Perrone, Pier Mario
    Antonangeli, Laura Maria
    Longo, Anna Beatrice Elena
    Carrer, Paolo
    Colosio, Claudio
    Consonni, Dario
    Marano, Giuseppe
    Boracchi, Patrizia
    Biganzoli, Elia
    Castaldi, Silvana
    VACCINES, 2024, 12 (03)
  • [38] Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study
    Yadete, Tesfaye
    Batra, Kavita
    Netski, Dale M.
    Antonio, Sabrina
    Patros, Michael J.
    Bester, Johan C.
    VACCINES, 2021, 9 (12)
  • [39] Teachers' Digital Competence in Basque Country during the COVID-19 pandemic
    Portillo-Berasaluce, Javier
    Ronnero, Ainara
    Tejada, Eneko
    REVISTA LATINOAMERICANA DE TECNOLOGIA EDUCATIVA-RELATEC, 2022, 21 (01): : 57 - 73
  • [40] COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects
    Zarebska-Michaluk, Dorota
    Hu, Chenlin
    Brzdek, Michal
    Flisiak, Robert
    Rzymski, Piotr
    VACCINES, 2022, 10 (08)